Ziv-aflibercept and bevacizumab for exudative age-related macular degeneration: A retrospective comparison of clinical outcomes and cost at 1 year

PURPOSE: The purpose of this study was to compare intravitreal ziv-aflibercept (IVZ) monotherapy to intravitreal bevacizumab (IVB) monotherapy in patients with exudative age-related macular degeneration (eAMD). MATERIALS AND METHODS: Patients with treatment-naïve eAMD treated with pro re nata (PRN)...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Sumit Randhir, Parikh, Ravi, Sakurada, Yoichi, Uplanchiwar, Bhushan, Mansour, Ahmad, Goud, Abhilash, Modi, Yasha S., Chhablani, Jay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7787097/
https://www.ncbi.nlm.nih.gov/pubmed/33437603
http://dx.doi.org/10.4103/tjo.tjo_3_20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7787097/
https://www.ncbi.nlm.nih.gov/pubmed/33437603
http://dx.doi.org/10.4103/tjo.tjo_3_20

Ejemplares similares